about
Lipid matrix plays a role in Abeta fibril kinetics and morphologyChemical Synthesis and Characterization of an Equinatoxin II(1-85) Analogue.Lipid composition regulates the conformation and insertion of the antimicrobial peptide maculatin 1.1.Membrane defects enhance the interaction of antimicrobial peptides, aurein 1.2 versus caerin 1.1.Pro-apoptotic bax-alpha1 synthesis and evidence for beta-sheet to alpha-helix conformational change as triggered by negatively charged lipid membranes.Proline facilitates membrane insertion of the antimicrobial peptide maculatin 1.1 via surface indentation and subsequent lipid disorderingA practical implementation of de-Pake-ing via weighted Fourier transformation.How is protein aggregation in amyloidogenic diseases modulated by biological membranes?Disordered proteins: biological membranes as two-dimensional aggregation matrices.Membrane interacting peptides: from killers to helpers.How Membrane-Active Peptides Get into Lipid Membranes.Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.Progression of NMR studies of membrane-active peptides from lipid bilayers to live cells.Total Chemical Synthesis of an Intra-A-Chain Cystathionine Human Insulin Analogue with Enhanced Thermal Stability.The lipid networkImplications of peptide assemblies in amyloid diseases.Membrane interactions of proline-rich antimicrobial peptide, Chex1-Arg20, multimers.Maculatin 1.1 disrupts Staphylococcus aureus lipid membranes via a pore mechanism.Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1.Disentanglement of heterogeneous dynamics in mixed lipid systems.Membrane interactions and biological activity of antimicrobial peptides from Australian scorpion.Melittin peptides exhibit different activity on different cells and model membranes.Interactions of a synthetic Leu-Lys-rich antimicrobial peptide with phospholipid bilayers.Antimicrobial Peptide Structures: From Model Membranes to Live Cells.Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.One pathogen two stones: are Australian tree frog antimicrobial peptides synergistic against human pathogens?Glycine Substitution Reduces Antimicrobial Activity and Helical Stretch of diPGLa-H in Lipid Micelles.High-Performance Coral Reef-like Carbon Nitrides: Synthesis and Application in Photocatalysis and Heavy Metal Ion Adsorption.Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria.Probing Ionic Liquid Electrolyte Structure via the Glassy State by Dynamic Nuclear Polarization NMR Spectroscopy.Membrane Insertion of a Dinuclear Polypyridylruthenium(II) Complex Revealed by Solid-State NMR and Molecular Dynamics Simulation: Implications for Selective Antibacterial Activity.Phase evolution of Na2O-Al2O3-SiO2-H2O gels in synthetic aluminosilicate binders.The Prototypic Cyclotide Kalata B1 Has a Unique Mechanism of Entering Cells.Dye-release assay for investigation of antimicrobial peptide activity in a competitive lipid environment.Proline-15 creates an amphipathic wedge in maculatin 1.1 peptides that drives lipid membrane disruption.Aggregation kinetics in the presence of brain lipids of Aβ(1-40) cleaved from a soluble fusion protein.Hypercrosslinked Additives for Ageless Gas-Separation Membranes.Elucidating the bactericidal mechanism of action of the linear antimicrobial tetrapeptide BRBR-NH2.Structural evolution of synthetic alkali-activated CaO-MgO-Na 2 O-Al 2 O 3 -SiO 2 materials is influenced by Mg contentInteraction of N-terminal peptide analogues of the Na+,K+-ATPase with membranes
P50
Q24293155-7CE68C07-ADFB-4315-814A-CD19D42DE375Q30400495-2AF32592-21BD-4D3F-8CDA-A77BE56DC039Q30405415-FE02B7EA-3C8E-4018-8311-8D7F6A671F0DQ30602988-82221CDD-7FA0-47B7-A007-5B35BDE4F3CBQ31077163-319F944B-31AF-4325-A2DA-1A4B54227F59Q36742771-A3579D83-9181-448E-AB77-C4C8F78C986CQ36772840-A555F847-B684-40E0-AD27-BCEA6DB59BBAQ37009881-80A22907-87A0-44A8-BF6F-710A8643BB9EQ37313990-EDD2A097-E99C-4281-A669-46D62ADF137BQ38057002-F1DA16F1-2622-4F48-A7B1-A0F2575CB61EQ38836313-7598A555-6903-4617-9801-21BD500D5002Q38931542-69479C46-4F0C-49EA-A79B-9F77729A3508Q39046525-1AD2360C-2DFC-4F72-8728-26BA68F265A9Q39120979-01C2BDCF-0314-45EC-B548-B5E2E28FEDC0Q39310861-5A636E11-E4D1-4B04-AB7A-0CAF085DF57BQ39431937-14154F5D-9AAE-42DE-9F1B-822CED7B48C2Q39960017-676E325B-8058-4E43-8824-07BC8D923469Q41790323-3190E5A7-659A-4898-8CBC-0C92206609E0Q41844800-8EA62F86-7566-4902-A0C0-0CCA0ADB6564Q41963668-FA01E419-F894-42BA-B07A-328B3A8F47D9Q44972534-B725F076-E563-4F4F-99D8-A7D20C6CA354Q45118992-AF4A2469-5A14-4F1C-9BC5-55378D043A1FQ46392270-A37EEEA2-BD8F-4402-8534-1FDF071DD1D3Q48131261-0B04C1D3-D87F-4E8A-B226-6BAD248A0C55Q48146758-18E2295D-7A5E-43C6-B008-54FACDC770D2Q48182008-771C2906-5F31-4C13-B62D-6BFE692D44F1Q48253572-CD7C47FA-83A5-4037-959F-7AF3DCAFBC64Q48299052-8B2A6D08-675E-433C-AE88-76254BE0687CQ49359694-05B549A4-8782-4FDA-848B-FEBA1DA80919Q50113304-3AAB4BC9-E5A4-40E5-9B1D-11523DB9C301Q50559320-F876ABFD-3282-4D47-AF35-BDAF07ACC419Q51497181-EA65692D-1CA6-45A9-8EBE-3F067D890E31Q51807255-34B953ED-9328-48C6-A049-FA46CFC58BB6Q52650878-A0D0EBB0-A3ED-4E67-B054-CE943828734FQ52661042-059DF6C4-07DA-46ED-AD9D-D45A09EC7F83Q52727307-81627569-E46E-4B37-840D-65F2E3050073Q53218159-2ACBD2A0-868E-4547-8341-1DF5922F7806Q54212572-6088FC9C-BDCF-46E8-9C89-191E323B6629Q59887441-2193CB85-CF54-49D6-9ED1-B78967B7C77BQ60194853-F40C7C8F-2431-4E79-BC68-8DFA66DA8713
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-3284-2176
@en
name
Marc-Antoine Sani
@ast
Marc-Antoine Sani
@en
Marc-Antoine Sani
@es
Marc-Antoine Sani
@nl
type
label
Marc-Antoine Sani
@ast
Marc-Antoine Sani
@en
Marc-Antoine Sani
@es
Marc-Antoine Sani
@nl
prefLabel
Marc-Antoine Sani
@ast
Marc-Antoine Sani
@en
Marc-Antoine Sani
@es
Marc-Antoine Sani
@nl
P106
P1153
10739378800
P21
P31
P496
0000-0003-3284-2176